Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival

Clinical Cancer Research

Volumn 14, Issue 21, 2008, Pages 6996-7003

  Li, Jun ^a,b   Guan, Hong Yu ^a,b   Gong, Li Yun ^a,b   Song, Li Bing ^c   Zhang, Nu ^b   Wu, Jueheng ^a,b   Yuan, Jie ^a,b   Zheng, Yi Jie ^a,d   Huang, Zheng Song ^b   Li, Mengfeng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d Department of Forensic Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SPHINGOSINE KINASE 1; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; BRAIN TUMOR; DISEASE COURSE; EVALUATION; GENE EXPRESSION; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 58149231552     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-0754     Document Type: Article

References (52)

1. Deorah S, Lynch CF, Sibenaller ZA, et al. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 2006;20:E1.
2. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 2006;24:1273-80.
3. Komotar RJ, Mocco J, Jones JE, et al. Pilomyxoid astrocytoma: diagnosis, prognosis, and management. Neurosurg Focus 2005;18:E7.
4. See SJ, Gilbert MR. Anaplastic astrocytoma: diagnosis, prognosis, and management. Semin Oncol 2004;31:618-34.
5. Kleihues P, Cavenee WK, editors. World Health Organization classification of tumours. Vol. 1. Lyon: IARC Press; 2000.
6. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancerpa thogenesis. Nat Rev Cancer20 07;7:763-77.
7. Malhi H, Gores GJ. Cancer therapy: back to metabolism. Cancer Biol Ther 2006;5:986-7.
8. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006;9:358-65.
9. Costello LC, Franklin RB. "Why do tumour cells glycolyse?": from glycolysis through citrate to lipogenesis. Mol Cell Biochem 2005;280:1-8.
10. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 2004;15:513-20.
11. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005;23:127-59.
12. Morales A, Fernandez-Checa JC. Pharmacological modulation of sphingolipids and role in disease and cancerc ell biology. Mini Rev Med Chem 2007;7:371-82.
13. Murph M, Tanaka T, Liu S, Mills GB. Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer. Clin Cancer Res 2006;12:6598-602.
14. Sabbadini RA. Targeting sphingosine-1-phosphate for cancer therapy. Br J Cancer 2006;95:1131-5.
15. Milstien S, Spiegel S Targeting sphingosine-1-phosphate: a novel avenue for cancer therapeutics. Cancer Cell 2006;9:148-50.
16. Pitson SM, D'Andrea RJ, Vandeleur L, et al. Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem J 2000;350:429-41.
17. Liu H, Sugiura M, Nava VE, et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000;275:19513-20.
18. Kohama T, Olivera A, Edsall L, et al. Molecular cloning and functional characterization of murine sphingosine kinase. J Biol Chem 1998;273:23722-8.
19. Olivera A, Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature1993;365:557-60.
20. Olivera A, Edsall L, Poulton S, et al. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCg. FASEB J 1999;13:1593-600.
21. Xia P, Wang L, Moretti PA, et al. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J Biol Chem 2002;277:7996-8003.
22. Lacaná E, Maceyka M, Milstien S, et al. Cloning and characterization of a protein kinase A anchoring protein (AKAP)-related protein that interacts with and regulates sphingosine kinase 1 activity. J Biol Chem 2002;277:32947-53.
23. Osawa Y, Banno Y, Nagaki M, et al. TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 2001;167:173-80.
24. 2+ mobilization requires intracellular sphingosine 1-phosphate production. Potential involvement of endogenous EDG-4 receptors. JBiol Chem 2000;275:38532-9.
25. Melendez A, Floto RA, Gillooly DJ, et al. FcgRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. JBiol Chem1998;273:9393-402.
26. Choi OH, Kim J-H, Kinet J-P. Calcium mobilization via sphingosine kinase in signalling by the FceRI antigen receptor. Nature 1996;380:634-6.
27. Xia P, Gamble JR, Wang L, et al. An oncogenic role of sphingosine kinase. Curr Biol 2000;10:1527-30.
28. Vann LR, Payne SG, Edsall LC, et al. Involvement of sphingosine kinase in TNF-α stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells. J Biol Chem 2002;277:12649-56.
29. Nava VE, Hobson JP, Murthy S, et al. Sphingosine kinase type 1 promotes estrogen dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 2002;281:115-27.
30. Sukocheva OA, Wang L, Albanese N, Vadas MA, Xia P. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol Endocrinol 2003;17:2002-12.
31. Sarkar S, Maceyka M, Hait NC, et al. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett 2005;579:5313-7.
32. Olivera A, Kohama T, Edsall L, et al. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. JCell Biol 1999;147:545-58.
33. Van Brocklyn JR, Jackson CA, Pearl DK, et al. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 2005;64:695-705.
34. Kohno M, Momoi M, Oo ML, et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol Cell Biol 2006;26:7211-23.
35. Le Scolan E, Pchejetski D, Banno Y, et al. Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood 2005;106:1808-16.
36. Akao Y, Banno Y, Nakagawa Y, et al. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their amptothecin-induced up-regulation. Biochem Biophys Res Commun 2006;342:1284-90.
37. Kawamori T, Osta W, Johnson KR, et al. Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J 2006;20:386-8.
38. Li J, Zhang N, Song L, et al. Astrocyte elevated gene-1 (AEG-1) is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008;14:3319-26.
39. Oskouian B, Saba J. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again. Cell Cycle 2007;6:522-7.
40. Alemany R, van Koppen CJ, Danneberg K, et al. Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch Pharmacol 2007;374:413-28.
41. Katsuma S, Hada Y, Ueda T, et al. Signaling mechanisms in sphingosine-phosphate-promoted mesangial cell proliferation. Genes Cells 2002;7:1217-30.
42. Döll F, Pfeilschifter J, Huwiler A. The epidermal growth factor stimulates sphingosine kinase-1 expression and activity in the human mammary carcinoma cell line MCF7. Biochim Biophys Acta 2005;1738:72-81.
43. Sobue S, Hagiwara K, Banno Y, et al. Transcription factors pecificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. JNeurochem 2005;95:940-9.
44. Murakami M, Ichihara M, Sobue S, et al. RET signaling-induced SPHK1 gene expression plays a role in both GDNF-induced differentiation and MEN2-type oncogenesis. J Neurochem 2007;102:1585-94.
45. Li Q-F, Huang W-R, Duan H-F, et al. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells. Oncogene 2007;26:7904-8.
46. Boily G, Larose J, Langlois S, et al Identification of transcripts modulated by ETV6 expression. Br J Haematol 2007;136:48-62.
47. Schwalm S, Döll F, Römer I, et al. Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. Biochem Biophys Res Commun 2008;368:1020-5.
48. Nakade Y, Banno Y, T-Koizumi K, et al Regulation of sphingosine kinase 1 gene expression by protein kinase C in a human leukemia cell line, MEG-O1. Biochim Biophys Acta 2003;1635:104-16.
49. Imamura T, Yamamoto S, Ohgane J, et al. Non-coding RNA directed DNA demethylation of Sphk1 CpG island. Biochem Biophys Res Commun 2004;322:593-600.
50. French KJ, Upson JJ, Keller SN, et al. Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 2006;318:596-603.
51. Pchejetski D, Golzio M, Bonhoure E, et al. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 2005;65:11667-75.
52. Radeff-Huang J, Seasholtz TM, Chang JW, et al. Tumor necrosis factor-α-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression. J Biol Chem 2007;282:863-70.